Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

RS Mehta, D Marin, A Alousi, CG Kanakry… - Blood …, 2023 - ashpublications.org
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …
被引用次数：15 相关文章
[HTML] nih.gov

[HTML][HTML] Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

RS Mehta, D Marin, A Alousi, CG Kanakry… - Blood …, 2023 - ncbi.nlm.nih.gov
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

RS Mehta, D Marin, A Alousi, CG Kanakry… - Blood …, 2023 - pubmed.ncbi.nlm.nih.gov
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

RS Mehta, D Marin, A Alousi… - Blood …, 2023 - mdanderson.elsevierpure.com
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …
[HTML] sciencedirect.com

[HTML][HTML] Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

RS Mehta, D Marin, A Alousi, CG Kanakry… - Blood Advances, 2023 - Elsevier
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

RS Mehta, D Marin, A Alousi, CG Kanakry… - Blood …, 2023 - experts.umn.edu
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type.

RS Mehta, D Marin, A Alousi, CG Kanakry… - Blood …, 2023 - europepmc.org
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type.

RS Mehta, DC Marin, A Alousi, CG Kanakry… - Blood …, 2023 - europepmc.org
Haploidentical hematopoietic cell transplantation (HCT) with post-transplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields similar …